
Recro Announces Amendment to Athyrium Credit Facility
MALVERN, PA — Recro Pharma, Inc. (NASDAQ: REPH), a contract development and manufacturing organization (CDMO) dedicated to solving complex formulation and manufacturing challenges for companies developing oral solid dose drug …
Read More